Status:
ACTIVE_NOT_RECRUITING
Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS)
Lead Sponsor:
Federal University of Paraíba
Collaborating Sponsors:
The City College of New York
Conditions:
Heart Failure, Reduced Ejection Fraction
Vitamin B12 Deficiency
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Reduced ejection fraction heart failure (HFrEF) is a complex and multifactorial condition. It is characterized by a decrease in the ability of the left ventricle to eject blood effectively during syst...
Detailed Description
This study is a controlled, double-blind, randomized, crossover model clinical trial involving 28 participants with HFrEF admitted to a hospital for surgery and post-surgical outpatient care. Assessme...
Eligibility Criteria
Inclusion
- Patients with stable HFrEF diagnosis and surgical indication;
- Adults and elderly people (20 to 80 years old);
- Able to respond to commands and give consent to participate in the research;
- Able to respond to simple commands and provide informed consent.
Exclusion
- Patients with a clinical history of neuromuscular or cognitive instability,
- Pregnancy and contraindications for receiving neurostimulation (such as cardiac pacemakers and metallic brain implants);
- Patients with contraindications to the use of Chlorella (gastritis, esophagitis, peptic ulcers),;
- Patients with stroke and tumors.
Key Trial Info
Start Date :
September 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06528366
Start Date
September 26 2023
End Date
August 30 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Paraíba
João Pessoa, Paraíba, Brazil, 58051-900